Answer
Ramipril is indicated to reduce cardiovascular morbidity and mortality in patients with manifest atherothrombotic cardiovascular disease (history of coronary heart disease or stroke, or peripheral vascular disease), or diabetes with at least one cardiovascular risk factor.
Sources for this answer
- Ramipril Aurobindo 5 mg TabletsAurobindo Pharma - Milpharm Ltd. · emc · SmPC §4.1 Therapeutic Indications · Version 9Document updated
Sources checked